This study aimed to explore the phase transition and disease progression in hepatitis B e antigen (HBeAg) negative indeterminate phase CHB patients with normal alanine aminotransferase (ALT)
*Both normal values: FibroTest < = 0.27 and ActiTest < = 0.29. **Survivals of patients with abnormal FibroTest and ActiTest were lower than those of normal FibroTest and ActiTest (p<0.005). ***Surviva
